The Australian patent represents the first patent granted for the Company's new point-of-care testing platform ...
Co-Diagnostics, Inc. ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback